CPT code 78227 represents hepatobiliary scintigraphy — a nuclear medicine imaging study that tracks bile production and flow to evaluate the liver, bile ducts, and gallbladder. The exam is clinically important for diagnosing bile duct obstruction or leakage, cholecystitis, gallstones, and other hepatobiliary disorders. It frequently involves administration of a medication to enhance diagnostic yield.

This analysis covers major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the service line, typical sites of care, and how the procedure is coded for national billing. The publication also provides benchmarking insights, common modifier usage, and policy or coverage considerations that affect payment and utilization across payers.

Intended for revenue cycle leaders, clinical managers, and policy analysts, the content outlines what to expect when billing CPT code 78227, summarizes payer coverage patterns, and highlights operational points relevant to ordering, scheduling, and claims submission. Data not available in the input is noted where applicable.